Cathay Biotech Inc (688065) — Cash Flow Reinvestment Rate
Cathay Biotech Inc (688065) has a Cash Flow Reinvestment Rate of 0.31x as of June 2025, reinvesting CN¥78.51 Million (capex CN¥78.51 Million ) from operating cash flow of CN¥251.82 Million. Explore 688065 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cathay Biotech Inc Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Cathay Biotech Inc across 7 annual periods. Also explore Cathay Biotech Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Cathay Biotech Inc (2017–2024)
Year-by-year capital reinvestment analysis for Cathay Biotech Inc. For live market cap and broader valuation context, see market value of Cathay Biotech Inc.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.03x | CN¥1.67 Billion | CN¥820.93 Million | CN¥843.31 Million | ▼ -63.1% |
| 2023 | 5.49x | CN¥3.13 Billion | CN¥569.45 Million | CN¥1.57 Billion | ▼ -47.4% |
| 2022 | 10.45x | CN¥8.40 Billion | CN¥803.67 Million | CN¥4.20 Billion | ▲ +287.8% |
| 2021 | 2.69x | CN¥1.60 Billion | CN¥594.18 Million | CN¥1.47 Billion | ▼ -29.2% |
| 2020 | 3.81x | CN¥1.96 Billion | CN¥514.96 Million | CN¥763.11 Million | ▼ -20.3% |
| 2019 | 4.78x | CN¥1.72 Billion | CN¥359.62 Million | CN¥511.14 Million | ▼ -74.3% |
| 2017 | 18.62x | CN¥995.09 Million | CN¥53.45 Million | CN¥995.09 Million | — |